Effects of oral casokefamide on plasma levels, tolerance, and intestinal transit in man

Citation
E. Schulte-frohlinde et al., Effects of oral casokefamide on plasma levels, tolerance, and intestinal transit in man, PEPTIDES, 21(3), 2000, pp. 439-442
Citations number
15
Categorie Soggetti
Biochemistry & Biophysics
Journal title
PEPTIDES
ISSN journal
01969781 → ACNP
Volume
21
Issue
3
Year of publication
2000
Pages
439 - 442
Database
ISI
SICI code
0196-9781(200003)21:3<439:EOOCOP>2.0.ZU;2-L
Abstract
Food-derived opioid peptides such as beta-casomorphins are of interest for treatment of chronic diarrhea. The beta-casomorphin analog casokefamide was administered orally at doses of 5.5, 8.0, and 16.0 mg to 10 healthy male v olunteers, respectively. Dose-dependent increases of plasma levels with a m aximum of 350 fmol/l were determined. No side-effects due to casokefamide h as been observed. In comparison to placebo, casokefamide showed a trend tow ard prolongation of oro-caecal transit time. Orally applied casokefamide is well tolerated and may represent a useful tool for treatment of diarrhea i n the future. (C) 2000 Elsevier Science Inc. All rights reserved.